Effects of sildenafil and metformin on endothelin-1 in the progression of pulmonary hypertension
Background: Pulmonary hypertension (PH) is a progressive and potentially fatal condition if left untreated. Currently, only sildenafil and bosentan have been approved by the FDA for the medical treatment of pediatric patients. The availability of bosentan, in a developing country, such as Indonesia...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Tripoli University
2025-07-01
|
| Seri Bilgileri: | Open Veterinary Journal |
| Konular: | |
| Online Erişim: | http://www.ejmanager.com/fulltextpdf.php?mno=247149 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
